Friday, May 12, 2017 News Recap HCV on the Rise in Boomers, Women and Children A new report from the CDC in the USA has found that HCV is concentrated among baby boomers and is increasing rapidly among new generations of Americans. In over just five years, the number of new hepatitis C virus infections reported to the CDC has nearly tripled, reaching a 15-year high. New hepatitis C virus infections are increasing most rapidly among young people, wi...
Deadly virus concentrated among baby boomers and increasing rapidly among new generations of Americans Over just five years, the number of new hepatitis C virus infections reported to CDC has nearly tripled, reaching a 15-year high, according to new preliminary surveillance data released today by the Centers for Disease Control and Prevention (CDC). Because hepatitis C has few symptoms, nearly half of people living with the virus don’t know they are in
A special Early Access to Medicines (EAMs) status has been granted in the UK to AbbVie’s as-yet-unapproved treatment for hepatitis C. The glecaprevir/pibrentasivr (g/p) combination is a ‘pan-genotypic’ drug currently under review by the European Medicines Agency, and is part of a rapid evolution in treatments for the potentially deadly liver infection. AbbVie is looking to compete with Gilead’s Epclusa, which was the first pan-genotypic hep C drug to
Women are more likely to share needles or start using intravenous drugs with a sexual partner than men are. Its cultural among IDUs. Women may more often have unprotected sex with an HCV-infected man for various reasons. So getting women into care & treatment & providing education to protect future infection is crucial. CDC Reports 213% Increase in Women of Child-Bearing Age....as a result of Heroin Epidemic....But in this Philadelphia study publi
Back in her hippie days, Elizabeth Rains was hitchhiking through Arizona in the rear of a truck when the drunk at the wheel crashed into a boulder. Rains needed close to 50 stitches in her head and may have had a blood transfusion. Two years later, in 1971, she received blood in a Montreal hospital to treat hemorrhaging after the birth of her second child. A year after that, she moved to Vancouver and endured rough sex with a drug-addicted boyfriend. Any
Scientists in Vancouver have developed a new screening tool that reveals the genetic signature of an individual’s hepatitis C virus so that doctors can customize their treatment. The tool, funded by Genome B.C. and devised by researchers at the B.C. Centre for Excellence in HIV/AIDS, could save money and lives, said Anita Howe, scientific lead for the hepatitis C program. “I would be able to tell you whether you are infected with a [virus] with resistant
WHO's hepatitis report reveals global impact of the disease. Awareness and education around hepatitis remain poor, with just 20% of people living with hep C aware of their status after getting tested, according to a new report. The World Health Organization’s first-of-its-kind investigation of the global hepatitis situation also found that only 9% of people living with hepatitis B knew they were affected. Between them the two strains account for 96% of
In April, your Member of Parliament received this invitation to attend a Hepatitis C Learning Event we are hosting on Parliament Hill on May 18th. Over the next few days, we need you to follow up with your MP and let him/her know that hepatitis C is an issue of important to you, and that you are hoping they will be in attendance. This is an excellent opportunity to engage our MPs on this important issue, and as with all of our network-d...
Thousands of Georgians have been cured of hepatitis C as a result of a giant experiment, in which the ex-Soviet nation tests the effectiveness of an aggressive public-health strategy. In the unprecedented project, all Georgians suffering from hepatitis C – an estimated 130,000 individuals – are being treated with expensive American medications free of charge. The program has entered its third year this May, and by 2020, Georgia hopes to be the first count
Although most people with hepatitis C virus can be cured, about 5 percent have more serious liver damage even after the virus is gone. A saliva test could identify genetic markers that indicate which people with hepatitis C and cirrhosis will benefit from certain treatments. Researchers say this test could help doctors predict outcomes after treating hepatitis C, and decrease the need for liver transplants. “Our findings further the move...